Molecular modeling of proteins: From simulations to drug design applications

Bioinformatics: A Swiss Perspective

Volumn , Issue , 2009, Pages 247-282

  Zoete, Vincent ^a   Cuendet, Michel ^a   Röhrig, Ute F ^a,b,c   Grosdidier, Aurélien ^a   Michielin, Olivier ^a,b,c  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DESIGN;

EID: 84970983677     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812838780_0010     Document Type: Chapter

References (71)

1. Grosdidier A, Zoete V, Michielin O. (2007) EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins67: 1010-1025.
2. Berneche S, Roux B. (2001) Energetics of ion conduction through the K+ channel. Nature414: 73-77.
3. Ma J, Karplus M. (1998). The allosteric mechanism of the chaperonin GroEL: a dynamic analysis. Proc Natl Acad Sci USA95: 8502-8507.
4. Dal Peraro M, Ruggerone P, Raugei S et al. (2007) Investigating biological systems using first principles Car-Parrinello molecular dynamics simulations. Curr Opin Struct Biol17: 149-1456.
5. van Vlijmen HW, Schaefer M, Karplus M. (1998) Improving the accuracy of protein pKa calculations: conformational averaging versus the average structure. Proteins33: 145-158.
6. Morea V, Lesk AM, Tramontano A. (2000) Antibody modeling: implications for engineering and design. Methods20: 267-279.
7. Liu Y, Gray NS. (2006). Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol2: 358-364.
8. Alder BJ, Wainwright TE. (1957) Phase transition for hard sphere systems. J Chem Phys27: 1208.
9. Alder BJ, Wainwright TE. (1959) Studies in molecular dynamics. I. General method. J Chem Phys31: 459.
10. Rahman A. (1964) Correlations in the motion of atoms in liquid argon. Phys Rev A136: 405-411.
11. Stillinger FH, Rahman A. (1974) Improved simulation of liquid water by molecular dynamics. J Chem Phys60: 1545-1557.
12. McCammon JA, Gelin BR, Karplus M. (1977) Dynamics of folded proteins. Nature267: 585-590.
13. Darden T, Perera L, Li L, Pedersen L. (1999) New tricks for modelers from thecrystallography toolkit: the particle mesh Ewald algorithm and its use in nucleicacid simulations. Structure7: R55-60.
14. Lamoureux G, Roux B. (2006) Absolute hydration free energy scale for alkali and halide ions established from simulations with a polarizable force field.J Phys Chem B110: 3308-3322.
15. Olsen L, Rydberg P, Rod TH, Ryde U. (2006) Prediction of activation energies for hydrogen abstraction by cytochrome p450. J Med Chem49: 6489-6499.
16. Dinner AR, Blackburn GM, Karplus M. (2001) Uracil-DNA glycosylase acts by substrate autocatalysis. Nature413: 752-755.
17. Chandler D. (1987). Introduction to Modern Statistical Mechanics. New York, NY: Oxford University Press.
18. Hoover WG. (1985) Canonical dynamics: equilibrium phase-space distributions. Phys Rev A31: 1695.
19. Tuckerman ME, Liu Y, Ciccotti G, Martyna GJ. (2001) Non-Hamiltonian molecular dynamics: generalizing Hamiltonian phase space principles to non- Hamiltonian systems. J Chem Phys115: 1678.
20. Huenenberger PH. (2005) Thermostat algorithms for molecular dynamics simulations. Adv Polym Sci 173: 105. 20. Berendsen HJC, Postma JPM, van Gunsteren WF et al. (1984) Molecular dynamics with coupling to an external bath. J Chem Phys81: 3684.
21. Morishita T. (2000) Fluctuation formulas in molecular-dynamics simulations with the weak coupling heat bath. J Chem Phys113: 2976.
22. Kirkwood JG. (1935) Statistical mechanics of fluid mixture. J Chem Phys3: 300-313.
23. Zwanzig RW. (1954) High-temperature equation of state by a perturbation method. I. Nonpolar gases. J Chem Phys22: 1420-1426.
24. Tembe BL, McCammon JA. (1984) Ligand-receptor interactions. Comput Chem8: 281-283.
25. Bash PA, Singh UC, Brown FK et al. (1987) Calculation of the relative change in binding free energy of a protein-inhibitor complex. Science235: 574-576.
26. Frenkel D, Smit B. (2002) Understanding Molecular Simulation: From Algorithms to Applications. San Diego, CA: Academic Press.
27. Bennett CH. (1976) Efficient estimation of free energy differences from Monte Carlo data. J Comput Phys22: 245-268.
28. Pitera JW, van Gunsteren WF. (2002) A comparison of non-bonded scaling approaches for free energy calculations. Mol Simul28: 45-65.
29. Beutler TC, Mark AE, van Schaik RC et al. (1994) Avoiding singularities and numerical instabilities in free energy calculations based on molecular simulations.Chem Phys Lett222: 529-539.
30. Straatsma TP, McCammon JA. (1991) Multiconfiguration thermodynamic integration. J Chem Phys95: 1175-1188.
31. van Gunsteren WF, Beutler TC, Fraternali F et al. (1993) Computation of free energy in practice: choice of approximations and accuracy limiting factors. In: van Gunsteren WF, Weiner PK, Wilkinson AJ (eds.). Computer Simulation ofBiomolecular Systems: Theoretical and Experimental Applications, Vol. 2. Leiden, The Netherlands: Escom Science Publishers, pp. 315-348.
32. Fasnacht M, Swendsen RH, Rosenberg JM. (2004) Adaptive integration method for Monte Carlo simulations. Phys Rev E Stat Nonlin Soft Matter Phys69: 056704.
33. Ytreberg FM, Swendsen RH, Zuckerman DM. (2006) Comparison of free energy methods for molecular systems. J Chem Phys125: 184114.
34. Michielin O, Karplus M. (2002) Binding free energy differences in a TCR peptide- MHC complex induced by a peptide mutation: a simulation analysis. J Mol Biol324: 547-569.
35. Oostenbrink C, van Gunsteren WF. (2005) Free energies of ligand binding for structurally diverse compounds. Proc Natl Acad Sci USA102: 6750-6754.
36. Swanson JM, Henchman RH, McCammon JA. (2004) Revisiting free energy calculations: a theoretical connection to MM/PBSA and direct calculation of the association free energy. Biophys J86: 67-74.
37. Srinivasan J, Cheatham TE, Cieplak P et al. (1998) Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices. J Am ChemSoc120: 9401-949.
38. Kollman PA, Massova I, Reyes C et al. (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res33: 889-897.
39. Gilson MK, Honig BH. (1988) Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins4: 7-18.
40. Gilson MK, Honig BH. (1988) Energetics of charge-charge interactions in proteins. Proteins3: 32-52.
41. Still WC, Tempczyk A, Hawley RC, Hendrickson T. (1990) Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc112: 6127-6129.
42. Gohlke H, Kiel C, Case DA. (2003) Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol330: 891-913.
43. Lee MS, Feig M, Salsbury FR Jr, Brooks CL III. (2003) New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations. J Comput Chem24: 1348-1356.
44. Lee MS, Salsbury FR Jr, Brooks CL III. (2002) Novel generalized Born methods. J Chem Phys116: 10606-10614.
45. Zoete V, Meuwly M, Karplus M. (2005) Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition. Proteins61: 79-93.
46. Amidon GL, Yalkowsky SH, Anik ST, Valvani SC. (1975). Solubility of nonelectrolytes in polar solvents. V. Estimation of the solubility of aliphatic monofunctional compounds in water using a molecular surface area approach. J Phys Chem79: 2239-2246.
47. Hermann RB. (1972) Theory of hydrophobic bonding. II. Correlation of hydrocarbon solubility in water with solvent cavity surface area. J Phys Chem76: 2754-2759.
48. Sitkoff D, Sharp KA, Honig B. (1994). Accurate calculation of hydration free energies using macroscopic solvent models. J Phys Chem98: 1978-1988.
49. Jayaram B, Sprous D, Beveridge DL. (1998) Solvation free energy of biomacromolecules: parameters for a modified generalized Born model consistent with the AMBER force field. J Phys Chem B102: 9571-9576.
50. Gohlke H, Kuhn LA, Case DA. (2004) Change in protein flexibility upon complex formation: analysis of Ras-Raf using molecular dynamics and a molecular framework approach. Proteins56: 322-337.
51. Tidor B, Karplus M. (1994) The contribution of vibrational entropy to molecular association. J Mol Biol 238: 405-14. 52. Moreira IS, Fernandes PA, Ramos MJ. (2007). Computational alanine scanning mutagenesis — an improved methodological approach. J Comput Chem28: 644-654.
52. Rizzo RC, Toba S, Kuntz ID.(2004) A molecular basis for the selectivity of thiadiazole urea inhibitors with stromelysin-1 and gelatinase-A from generalized Born molecular dynamics simulations. J Med Chem47: 3065-30674.
53. Pearlman DA. (2005) Evaluating the molecular mechanics Poisson-Boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase. J Med Chem48: 7796-7807.
54. Foloppe N, Hubbard R. (2006) Towards predictive ligand design with freeenergy based computational methods? Curr Med Chem13: 3583-3608.
55. Kuhn B, Gerber P, Schulz-Gasch T, Stahl M. (2005) Validation and use of the MM-PBSA approach for drug discovery. J Med Chem48: 4040-4048.
56. Huo S, Massova I, Kollman PA. (2002) Computational alanine scanning of the 1: 1 human growth hormone-receptor complex. J Comput Chem23: 15-27.
57. Massova I, Kollman PA. (1999) Computational alanine scanning to probe protein protein interactions: a novel approach to evaluate binding free energies.J Am Chem Soc121: 8133-8143.
58. Zoete V, Michielin O. (2007) Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex.Proteins67: 1026-1047.
59. Lafont V, Schaefer M, Stote RH et al. (2007) Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies “efficient amino acids”. Proteins67: 418-434.
60. Zoete V, Meuwly M. (2006) Importance of individual side chains for the stability of a protein fold: computational alanine scanning of the insulin monomer.J Comput Chem27: 1843-1857.
61. Yip YL, Zoete V, Scheib H, Michielin O. (2006) Structural assessment of single amino acid mutations: application to TP53 function. Hum Mutat27: 926-937.
62. Michalik L, Zoete V, Krey G et al. (2007) Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferatoractivated receptor alpha helix 12 dynamic behavior. J Biol Chem282: 9666-9677.
63. Sono M, Roach MP, Coulter ED, Dawson JH. (1996) Heme-containing oxygenases. Chem Rev96: 2841-2888.
64. Uyttenhove C, Pilotte L, Theate I et al. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med9: 1269-1274.
65. Muller AJ, DuHadaway JB, Donover PS et al. (2005). Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med11: 312-319.
66. Brastianos HC, Vottero E, Patrick BO et al. (2006) Exiguamine A, an indoleamine- 2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosiaexigua. J Am Chem Soc128: 16046-16047.
67. Pereira A, Vottero E, Roberge M et al. (2006) Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific marine hydroid Garveia annulata.J Nat Prod69: 1496-1499.
68. Kumar S, Malachowski WP, DuHadaway JB et al. (2008) Indoleamine 2,3 dioxygenase is the anticancer target for a novel series of potent naphthoquinonebased inhibitors. J Med Chem51: 1706-17018.
69. Sugimoto H, Oda S, Otsuki T et al. (2006). Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proc Natl Acad Sci USA103: 2611-2616.
70. Bemis GW, Murcko MA. (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem39: 2887-2893.
71. Bemis GW, Murcko MA. (1999) Properties of known drugs. 2. Side chains. J Med Chem42: 5095-5099.